| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | June, 2022  Vol. 40  No.2 Previous Issue | Next Issue | Archive
In this issue:



Review Article
89 An overview of radiation-induced heart disease
Samer Ellahham, Amani Khalouf, Mohammed Elkhazendar, Nour Dababo, Yosef Manla
Radiat Oncol J. 2022;40(2):89-102.   Published online 2022 Jun 21     DOI: https://doi.org/10.3857/roj.2021.00766
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 8  Crossref 14
Original Articles
Clinical Investigations
103 Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
Candan Demiroz Abakay, Sonay Arslan, Meral Kurt, Sibel Cetintas
Radiat Oncol J. 2022;40(2):103-110.   Published online 2022 May 25     DOI: https://doi.org/10.3857/roj.2021.00864
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Crossref 1
111 Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2022;40(2):111-119.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01060
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 7  Crossref 7
120 Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu
Radiat Oncol J. 2022;40(2):120-126.   Published online 2022 May 17     DOI: https://doi.org/10.3857/roj.2021.01025
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 2  Crossref 2
127 Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam
Radiat Oncol J. 2022;40(2):127-140.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01053
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 3  Crossref 4
141 Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Chawalit Lertbutsayanukul, Manida Pitak, Chonnipa Nantavithya
Radiat Oncol J. 2022;40(2):141-150.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.00927
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 3  Crossref 2
151 Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis
Radiat Oncol J. 2022;40(2):151-161.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01032
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
Case Report
162 Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Rahul N. Prasad, Peter J. Kobalka, Haley K. Perlow, Daniel M. Prevedello, Dukagjin M. Blakaj, Raju R. Raval, Joshua D. Palmer
Radiat Oncol J. 2022;40(2):162-168.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01074
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 2.3
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Elekta Korea
DAWON MEDAX
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next